Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
1 clinical trials · Condition
◉ Watch Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
| Record | Firm | Date |
|---|---|---|
| Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer (NCT06280508) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-03-01 |
Track Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence automatically
Every clearance here is in the API, with alerts when new ones post.